Depression in multiple sclerosis: a review

R J Siegert, D A Abernethy, R J Siegert, D A Abernethy

Abstract

Several studies have reported high rates of depression in multiple sclerosis (MS) with a lifetime prevalence of approximately 50% and an annual prevalence of 20% not uncommon. Concern about the potential of new drug treatments to exacerbate or precipitate depression in MS has led to increased interest in the relation between MS and depression. This review on MS and depression identifies the following key issues: How common is depression in people with MS? Is depression in MS associated with lesions in specific regions of the central nervous system? Is there an increased risk of suicide in MS? Is there a higher than expected incidence of anxiety disorders in MS? Are fatigue and depressed mood related in MS? Is there a relation between depression and cognitive impairment in MS? Which psychosocial variables affect the development of depression in MS? Does treatment with interferon increase the risk of depression? How effective are treatments for MS patients with depression? Each of these issues is briefly reviewed with critical commentary, and some priorities for future research are suggested.

References

    1. Mult Scler. 2003 Jun;9(3):307-10
    1. Gen Hosp Psychiatry. 1987 Nov;9(6):426-34
    1. Mult Scler. 2003 Feb;9(1):89-94
    1. Am J Psychiatry. 2002 Nov;159(11):1862-8
    1. Arch Neurol. 1987 Apr;44(4):376-8
    1. Neurology. 1997 Oct;49(4):1105-10
    1. Neurology. 2002 Sep 10;59(5):674-8
    1. J Behav Med. 1999 Apr;22(2):127-42
    1. J Neurol Neurosurg Psychiatry. 1992 Jul;55(7):542-5
    1. Arch Phys Med Rehabil. 1996 Feb;77(2):165-70
    1. Mult Scler. 2000 Oct;6(5):343-8
    1. Br J Clin Psychol. 1991 Nov;30 ( Pt 4):333-48
    1. Mult Scler. 2003 Aug;9(4):393-6
    1. Neurology. 2004 Feb 24;62(4):586-90
    1. Can J Psychiatry. 2004 Mar;49(3):157-63
    1. Neuropsychology. 1999 Jul;13(3):434-46
    1. Neuropsychol Rev. 1998 Jun;8(2):43-77
    1. Annu Rev Psychol. 2004;55:745-74
    1. Neurology. 2002 Sep 10;59(5):744-6
    1. Acta Neurol Scand. 2003 Dec;108(6):389-95
    1. J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):661-3
    1. N Engl J Med. 2000 Sep 28;343(13):898-904
    1. Arch Neurol. 1988 Apr;45(4):435-7
    1. Arch Clin Neuropsychol. 2002 Feb;17(2):103-15
    1. Can J Psychiatry. 2002 Sep;47(7):686
    1. Clin Rehabil. 2000 Feb;14(1):50-4
    1. Health Psychol. 1999 Jul;18(4):383-92
    1. Mult Scler. 2003 Dec;9(6):616-20
    1. J Neurol. 2002 Jul;249(7):815-20
    1. Am J Psychiatry. 1997 Mar;154(3):408-14
    1. Mult Scler. 2003 Jun;9(3):284-8
    1. Psychol Med. 2004 Apr;34(3):533-41
    1. J Int Neuropsychol Soc. 2001 Sep;7(6):665-74
    1. Mult Scler. 2001 Dec;7(6):411-6
    1. J Neurol Sci. 2004 Feb 15;217(2):211-6
    1. Depress Anxiety. 2004;19(3):137-45
    1. Neurology. 1994 Jan;44(1):188; author reply 188-90
    1. Neurology. 1996 Mar;46(3):628-32
    1. J Psychosom Res. 1998 Jul;45(1):33-8
    1. Psychol Bull. 1993 Mar;113(2):247-78
    1. Arch Neurol. 1996 Jul;53(7):642-9
    1. Neurology. 2003 Dec 9;61(11):1524-7
    1. Mult Scler. 2000 Jun;6(3):181-5
    1. Neuropsychol Rev. 2003 Jun;13(2):93-112
    1. Arch Neurol. 1999 Oct;56(10):1263-5
    1. Neurology. 1991 Aug;41(8):1193-6
    1. J Neurol. 2001 May;248(5):416-21
    1. Mult Scler. 2001 Aug;7(4):243-8
    1. J Neurol Sci. 2002 Dec 15;205(1):51-8
    1. Psychol Med. 1989 Nov;19(4):887-95
    1. J Clin Psychiatry. 2000 Sep;61(9):643-8
    1. Psychosom Med. 2003 Jul-Aug;65(4):542-7
    1. J Rehabil Res Dev. 2002 Mar-Apr;39(2):211-24
    1. Psychol Med. 1997 Sep;27(5):989-94
    1. J Psychosom Res. 2004 Mar;56(3):355-61
    1. Brain. 2002 Jul;125(Pt 7):1428-49
    1. Curr Opin Neurol. 1995 Jun;8(3):216-20
    1. Med J Aust. 1996 May 20;164(10):585-8
    1. Psychol Med. 2004 Jan;34(1):37-49
    1. Arch Neurol. 1987 Feb;44(2):187-90
    1. Arch Neurol. 1989 Oct;46(10):1121-3
    1. J Clin Exp Neuropsychol. 1998 Jun;20(3):376-90
    1. Biol Psychiatry. 2000 Oct 15;48(8):813-29
    1. J Clin Exp Neuropsychol. 1986 Oct;8(5):503-42
    1. Br J Psychiatry. 2001 Feb;178:145-53
    1. Acta Neurol Scand. 2004 Jul;110(1):6-13
    1. Cogn Neuropsychiatry. 2003 Aug;8(3):161-71
    1. Neurology. 1991 May;41(5):685-91
    1. Am J Psychiatry. 1990 Nov;147(11):1493-7
    1. Neuropsychol Rev. 2003 Mar;13(1):33-42
    1. Clin Rehabil. 2001 Dec;15(6):657-68
    1. Neurology. 1991 May;41(5):692-6
    1. Brain. 1986 Aug;109 ( Pt 4):585-97
    1. Mult Scler. 2004 Feb;10(1):80-4
    1. J Psychosom Res. 2002 Sep;53(3):775-81
    1. Neuropsychology. 1999 Oct;13(4):546-56
    1. J Consult Clin Psychol. 2001 Dec;69(6):942-9

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit